InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,259.23
(
-0.90%
)
US TECH 100
18,118.00
(
-0.61%
)
Dow Jones
39,042.88
(
-1.58%
)
Brent Oil
81.16
(
-0.46%
)
Bitcoin
67,332.87
(
-2.56%
)
Post# of 251908
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

novicetrader

Send PM Follow Ignore
Followers 40
Posts 6504
Boards Moderated 0
Alias Born 11/16/2003

novicetrader

Re: DewDiligence post# 250120

Monday, 12/18/2023 3:11:01 PM

Monday, December 18, 2023 3:11:01 PM

Post# of 251908
GPCR-if we look only at the weightloss side, a 4.7% decrease in 8 weeks isn't too bad,IMO. But since today's result is primarily for Diabetes, overall doesn't look great.Was wondering if the drug can be looked at only from the weight angle, will they need to start a freshTrial? Or, can they go ahead with the data & diverge into just a weightloss strategy? Many more players will be needed in the weight loss category, besides the 2 bigwigs(LLY & Novo)
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up